Cost analysis of unilateral and bilateral pallidotomy for Parkinson's disease

J Clin Neurosci. 2004 Nov;11(8):829-34. doi: 10.1016/j.jocn.2004.03.007.

Abstract

With the rapid increase in provision of deep brain stimulation for Parkinson's disease, the efficacy of pallidotomy in symptom alleviation appears to be increasingly ignored. We demonstrate that lesional surgery is effective with benefit over a significant period of time with very significant societal cost savings. Such studies are essential for future planning of services so that maximum numbers of patients can benefit from surgery, both lesional and neuromodulation, as deemed appropriate.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / economics
  • Antiparkinson Agents / therapeutic use
  • Cohort Studies
  • Costs and Cost Analysis / methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurologic Examination
  • Pallidotomy / economics*
  • Pallidotomy / methods*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / economics*
  • Parkinson Disease / surgery*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antiparkinson Agents